What's new

EMEA-002169-PIP01-17-M03

EMEA-002169-PIP01-17-M03

Jun 24, 2025 - 12:30
 0
EMEA-002169-PIP01-17-M03
EMEA-002169-PIP01-17-M03
Read More

Tags:

Previous Article

STAT+: Nuvalent says its ROS1-targeted drug shrank lung tumors in patients who f...

Next Article

How fragile is Europe’s gas supply?

Related Posts

EMEA-002999-PIP01-21-M01

EMEA-002999-PIP01-21-M01

Jun 12, 2025  0

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0